(Q52142003)

English

Different diagnostic values of imaging parameters to predict pseudoprogression in glioblastoma subgroups stratified by MGMT promoter methylation.

scientific article published on 5 April 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/27048531

Different diagnostic values of imaging parameters to predict pseudoprogression in glioblastoma subgroups stratified by MGMT promoter methylation. (English)

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/27048531

1 reference

based on heuristic

inferred from title

author name string

Ra Gyoung Yoon

1

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/27048531

Ho Sung Kim

2

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/27048531

Wooyul Paik

3

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/27048531

Woo Hyun Shim

4

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/27048531

Sang Joon Kim

5

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/27048531

Jeong Hoon Kim

6

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/27048531

language of work or name

0 references

publication date

5 April 2016

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/27048531

European Radiology

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/27048531

27

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/27048531

1

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/27048531

255-266

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/27048531

https://scigraph.springernature.com/pub.10.1007/s00330-016-4346-y

0 references

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

Diagnostic dilemma of pseudoprogression in the treatment of newly diagnosed glioblastomas: the role of assessing relative cerebral blood flow volume and oxygen-6-methylguanine-DNA methyltransferase promoter methylation status.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

Pseudoprogression in Patients with Glioblastoma: Assessment by Using Volume-weighted Voxel-based Multiparametric Clustering of MR Imaging Data in an Independent Test Set.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-016-4346-Y

21 January 2018

Index for rating diagnostic tests

1 reference

https://pubmed.ncbi.nlm.nih.gov/27048531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27048531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/27048531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00330-016-4346-Y

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/27048531

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/27048531

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52142003&oldid=1534859356"